ior® EPOCIM

2 trials

Sponsors

Center of Molecular Immunology (CIM)

Conditions

Cardiovascular, renal and respiratory disorders in convalescent patients from SARS-CoV-2 infection COVID-19 SARS-CoV2Chronic Kidney Disease -

Phase 2

ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders

Active, not recruitingRPCEC00000376

Center of Molecular Immunology (CIM)Cardiovascular, renal and respiratory disorders in convalescent patients from SARS-CoV-2 infection COVID-19 SARS-CoV2

Start: 2022-01-07Target: 135Updated: 2026-10-05

Unknown Phase

Post–authorizacion study on safety in sentinel sites in adult patients with chronic kidney disease undergoing dialysis

Active, not recruitingRPCEC00000486

Center of Molecular Immunology (CIM)Chronic Kidney Disease -

Start: 2026-10-19Updated: 2026-10-05